EXAS vs PCG · rev $2.76B vs P/E 13, $37.68B cap
EXACT Sciences Corporation (EXAS) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
PCG does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the EXAS and PCG stock pages for the full models.
Not investment advice.